CPD ACTIVITY
Addressing the gap in Lipid treatment

Dear {{customText[Dr. | Sr. | Mr. | Mrs. | Ms. | Prof.]}} {{accLname}},

I trust that you and your family are keeping well.

Herein the second of the two-part series of short videos introducing the concepts of the need for an individualised approach to cholesterol lowering treatment, as well as what is meant by the term “residual cardiovascular risk”. I hope that you managed to watch the first video and found it informative.

I trust that you will find this of value to your practice.

Best regards,

{{userName}}

Organon Professional Representative

{{userEmailAddress}}

Video 2: Residual Cardiovascular Risk
Her Health. Our every day
organon

We believe in a better and healthier every day for every woman.

Our mission is to deliver impactful medicines and solutions for a healthier every day.

MSD
Organon

 

 

You are receiving this email because you have been identified as a valuable customer and we respect your privacy.

For more information on how we treat your personal information, please see our privacy notice

If you no longer wish to receive further emails, please unsubscribe here.